The Attractiveness of Opposites: Agonists and Antagonists.

Hdl Handle:
http://hdl.handle.net/10147/348559
Title:
The Attractiveness of Opposites: Agonists and Antagonists.
Authors:
O'Brien, Tony
Citation:
O'Brien, Tony. The Attractiveness of Opposites: Agonists and Antagonists. 2015: J Pain Palliat Care Pharmacother
Journal:
Journal of pain & palliative care pharmacotherapy
Issue Date:
2-Feb-2015
URI:
http://hdl.handle.net/10147/348559
DOI:
10.3109/15360288.2014.1003680
PubMed ID:
25643224
Abstract:
ABSTRACT Opioid-induced bowel dysfunction, of which constipation is the most common aspect, is a major limiting factor in the use of opioids for pain management. The availability of an oral, long-acting formulation of oxycodone and naloxone represents a highly significant development in pain management. The combination of an opioid analgesic with an opioid antagonist offers reliable pain control with a significant reduction in the burden of opioid-induced constipation. This report is adapted from paineurope 2014; Issue 3, ©Haymarket Medical Publications Ltd, and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, LTD and is distributed free of charge to healthcare professionals in Europe. Archival issues can be accessed via the website: http://www.paineurope.com at which European health professionals can register online to receive copies of the quarterly publication.
Item Type:
Article
Language:
en
Description:
Opioid-induced bowel dysfunction, of which constipation is the most common aspect, is a major limiting factor in the use of opioids for pain management. The availability of an oral, long-acting formulation of oxycodone and naloxone represents a highly significant development in pain management. The combination of an opioid analgesic with an opioid antagonist offers reliable pain control with a significant reduction in the burden of opioid-induced constipation. This report is adapted from paineurope 2014; Issue 3, ©Haymarket Medical Publications Ltd, and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, LTD and is distributed free of charge to healthcare professionals in Europe. Archival issues can be accessed via the website: http://www.paineurope.com at which European health professionals can register online to receive copies of the quarterly publication.
Keywords:
QUALITY OF LIFE; PAIN MANAGEMENT
Local subject classification:
BOWEL DYSFUNCTION; OPIOID; NALOXONE
ISSN:
1536-0539

Full metadata record

DC FieldValue Language
dc.contributor.authorO'Brien, Tonyen
dc.date.accessioned2015-04-07T08:28:57Zen
dc.date.available2015-04-07T08:28:57Zen
dc.date.issued2015-02-02en
dc.identifier.citationO'Brien, Tony. The Attractiveness of Opposites: Agonists and Antagonists. 2015: J Pain Palliat Care Pharmacotheren
dc.identifier.issn1536-0539en
dc.identifier.pmid25643224en
dc.identifier.doi10.3109/15360288.2014.1003680en
dc.identifier.urihttp://hdl.handle.net/10147/348559en
dc.descriptionOpioid-induced bowel dysfunction, of which constipation is the most common aspect, is a major limiting factor in the use of opioids for pain management. The availability of an oral, long-acting formulation of oxycodone and naloxone represents a highly significant development in pain management. The combination of an opioid analgesic with an opioid antagonist offers reliable pain control with a significant reduction in the burden of opioid-induced constipation. This report is adapted from paineurope 2014; Issue 3, ©Haymarket Medical Publications Ltd, and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, LTD and is distributed free of charge to healthcare professionals in Europe. Archival issues can be accessed via the website: http://www.paineurope.com at which European health professionals can register online to receive copies of the quarterly publication.en
dc.description.abstractABSTRACT Opioid-induced bowel dysfunction, of which constipation is the most common aspect, is a major limiting factor in the use of opioids for pain management. The availability of an oral, long-acting formulation of oxycodone and naloxone represents a highly significant development in pain management. The combination of an opioid analgesic with an opioid antagonist offers reliable pain control with a significant reduction in the burden of opioid-induced constipation. This report is adapted from paineurope 2014; Issue 3, ©Haymarket Medical Publications Ltd, and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, LTD and is distributed free of charge to healthcare professionals in Europe. Archival issues can be accessed via the website: http://www.paineurope.com at which European health professionals can register online to receive copies of the quarterly publication.en
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to Journal of pain & palliative care pharmacotherapyen
dc.subjectQUALITY OF LIFEen
dc.subjectPAIN MANAGEMENTen
dc.subject.otherBOWEL DYSFUNCTIONen
dc.subject.otherOPIOIDen
dc.subject.otherNALOXONEen
dc.titleThe Attractiveness of Opposites: Agonists and Antagonists.en
dc.typeArticleen
dc.identifier.journalJournal of pain & palliative care pharmacotherapyen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.